Hologic has announced approval of the NovaSure V5 global endometrial ablation, or GEA, device in Canada and Europe. This new version incorporates enhanced features designed to treat a wide range of cervical and uterine anatomies. It builds on a track record for NovaSure, including 3M patients who have benefited from the device.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on HOLX: